drugset / Trial / NCT01824446

AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184

NCT01824446 ↗

Phase 1 Completed 6 enrolled Shire
NaSingle-groupOpen-labelBasic science

Summary

To evaluate how the body absorbs, metabolizes (breaks down) and excretes (eliminates) the study drug. Further, the study will determine how much of the study drug gets into the bloodstream and how long it takes the body to get rid of it when given as a single dose to healthy male subjects.

Timeline

Start
2013-05-01
Primary completion
2013-05-29
Completion
2013-05-29

Drugs

EvaluationDrugModalityDoseRoute
Subject DEFERITAZOLE Small molecule 3 g Oral

Indications

No indication recorded.